|
13 Apr 2025 |
Max Healthcare
|
Consensus Share Price Target
|
1089.30 |
1151.18 |
- |
5.68 |
buy
|
|
|
|
|
10 Apr 2025
|
Max Healthcare
|
Geojit BNP Paribas
|
1089.30
|
1240.00
|
1123.15
(-3.01%)
|
13.83 |
Accumulate
|
|
|
|
|
04 Feb 2025
|
Max Healthcare
|
Edelweiss
|
1089.30
|
1320.00
|
1174.30
(-7.24%)
|
21.18 |
Buy
|
|
|
Bed expansion to bolster growth
|
|
01 Feb 2025
|
Max Healthcare
|
Axis Direct
|
1089.30
|
1315.00
|
1108.25
(-1.71%)
|
20.72 |
Buy
|
|
|
We maintain a BUY rating on MAXHEALTH with a target price of Rs 1,315/share, representing an upside potential of 26% from the CMP.
|
|
11 Dec 2024
|
Max Healthcare
|
Axis Direct
|
1089.30
|
1315.00
|
1132.20
(-3.79%)
|
20.72 |
Buy
|
|
|
We Initiate coverage on Max Healthcare Ltd. with a BUY rating and a target price of Rs 1,315/share, offering a 18% upside from the CMP.
|
|
25 Nov 2024
|
Max Healthcare
|
FundsIndia
|
1089.30
|
1185.00
|
971.75
(12.10%)
|
Target met |
Buy
|
|
|
|
|
07 Nov 2024
|
Max Healthcare
|
Motilal Oswal
|
1089.30
|
1240.00
|
1078.75
(0.98%)
|
13.83 |
Buy
|
|
|
Max Healthcare (MAXH) delivered slightly better-than-expected operational performance in 2QFY25. The annualized EBITDA per bed improved to INR7.8m from INR7.0m QoQ at its existing centers.
|
|
20 Sep 2024
|
Max Healthcare
|
Motilal Oswal
|
1089.30
|
1240.00
|
1067.95
(2.00%)
|
13.83 |
Buy
|
|
|
Max Healthcare (MAXHEALT) has aggressively increased its bed capacity through both organic and inorganic routes over the past three years.
|
|
20 Sep 2024
|
Max Healthcare
|
IDBI Capital
|
1089.30
|
1050.00
|
1067.95
(2.00%)
|
Target met |
Buy
|
|
|
|
|
27 Jun 2024
|
Max Healthcare
|
IDBI Capital
|
1089.30
|
1050.00
|
920.75
(18.31%)
|
Target met |
Buy
|
|
|
|
|
23 May 2024
|
Max Healthcare
|
Motilal Oswal
|
1089.30
|
930.00
|
803.05
(35.65%)
|
Target met |
Buy
|
|
|
Max Healthcare (MAX) delivered in-line performance for 4QFY24. The quarterly EBITDA continues to inch up since the listing (Aug’20), reaching INR4.9b for 4QFY24. Max has demonstrated superior execution across its hospitals, Max Lab, and Max@home segments, supported by a growing number of patients and improved realizations.
|
|
07 Nov 2023
|
Max Healthcare
|
Motilal Oswal
|
1089.30
|
700.00
|
597.45
(82.32%)
|
Target met |
Buy
|
|
|
|
|
30 Aug 2023
|
Max Healthcare
|
Motilal Oswal
|
1089.30
|
660.00
|
575.35
(89.33%)
|
Target met |
Buy
|
|
|
|
|
10 Aug 2023
|
Max Healthcare
|
Edelweiss
|
1089.30
|
680.00
|
536.75
(102.94%)
|
Target met |
Buy
|
|
|
Healthy run continues
|
|
17 May 2023
|
Max Healthcare
|
Prabhudas Lilladhar
|
1089.30
|
565.00
|
522.60
(108.44%)
|
Target met |
Buy
|
|
|
|
|
17 May 2023
|
Max Healthcare
|
Motilal Oswal
|
1089.30
|
600.00
|
522.60
(108.44%)
|
Target met |
Buy
|
|
|
|
|
09 May 2023
|
Max Healthcare
|
SBI Securities
|
1089.30
|
553.00
|
481.30
(126.32%)
|
Target met |
Buy
|
|
|
|
|
07 Apr 2023
|
Max Healthcare
|
Motilal Oswal
|
1089.30
|
530.00
|
430.35
(153.12%)
|
Target met |
Buy
|
|
|
|
|
05 Feb 2023
|
Max Healthcare
|
Prabhudas Lilladhar
|
1089.30
|
500.00
|
435.50
(150.13%)
|
Target met |
Buy
|
|
|
|
|
03 Nov 2022
|
Max Healthcare
|
Prabhudas Lilladhar
|
1089.30
|
500.00
|
462.85
(135.35%)
|
Target met |
Buy
|
|
|
|
|
13 Aug 2022
|
Max Healthcare
|
Prabhudas Lilladhar
|
1089.30
|
427.00
|
396.85
(174.49%)
|
Target met |
Buy
|
|
|
|